ask="0.370"
ask_size="9500"
average_daily_volume="1841800"
bid="0.292"
bid_size="7500"
book_value="0.168"
change="-0.001"
change_from_200_day_moving_average="-0.022"
change_from_50_day_moving_average="0.018"
change_from_52_week_high="-0.797"
change_From_52_week_low="0.041"
change_in_percent="-0.278%"
close="0.323"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.204"
ebitda="-41.64M"
eps_estimate_current_year="-0.130"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.327"
high_52_weeks="1.120"
last_trade_date="2/8/2017"
last_trade_price="0.323"
last_trade_size="16097"
last_trade_time="4:00pm"
low="0.310"
low_52_weeks="0.282"
market_capitalization="83.06M"
moving_average_200_day="0.345"
moving_average_50_day="0.305"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.250"
open="0.327"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-6.327%"
percent_change_from_50_day_moving_average="+5.744%"
percent_change_from_52_week_high="-71.161%"
percent_change_from_52_week_low="+14.539%"
previous_close="0.324"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.928"
price_per_sales="1.529"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.330"
stock_exchange="NCM"
symbol="PPHM"
volume="1265444"
weeks_range_52="0.282 - 1.120"
